Business Standard
The gains come amid the background of strong economic data and optimism around the functioning of the new government
The 10-year benchmark bond yield inched up to 7.02 per cent during the day as traders sold their securities at a profit
To boost participation of small investors in the securities market, Sebi on Friday increased the threshold for the basic service demat account to Rs 1
Orchid Pharma announced the launch of its new drug - Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract i
Bharat Electronics (BEL), has signed a contract valued at Rs.3,172 crore with Armoured Vehicles Nigam (AVNL) on 28 June 2024, at AVNL Headquarters in
TWO95 International Inc (TWO95) is based in New Jersey, USA. TWO95 has been engaged in technology solutions and services relating to digital transform
Deploys its flagship Healthcare AIOT Product - 'Truhealthz' in ESI Primary Healthcare Centres in Assam State
Zydus Lifesciences and Dr. Reddy's Laboratories announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.
The initial public offer of Vraj Iron and Steel got subscribed 119 times on the last day of bidding on Friday helped by heavy participation from insti
Consequent upon said allotment of 1,88,96,100 equity shares by AFAL, GPIL's holding in AFAL has increased from 78.96% to 88.34% in the enhanced equity
The Nifty closed at 24,011, down 34 points, or 0.14 per cent, as gains in Reliance Industries (RIL) were offset by losses in banking
Industrials stocks were trading in the negative zone, with the BSE Industrials index falling 24.14 points or 0.15% at 15685.91 at 13:47 IST.
Capital Goods stocks were trading in the negative zone, with the BSE Capital Goods index falling 170.85 points or 0.24% at 72457.93 at 13:47 IST.
Central Depository Services (India) (CDSL) zoomed 15.04% to Rs 2,308 after the company announced that its board will meet on Tuesday, 02 July 2024, to
Shares of Black Box (formerly AGC Networks) surged 20% to hit a new high of Rs 384 on the BSE in Friday's intra-day trade amid heavy volumes.
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for
Polycab India declined 3.13% to Rs 6771 following large block deal took place in earlier today, 28 June 2024.
Nephro Care India IPO: This NSE-SME IPO was subscribed 5.5 times within hours on Day 1 of the offer period.
Shares of Polycab India dropped 5.3 per cent at Rs 6,616 on the NSE in Friday's intraday deals
Indian Bank is quoting at Rs 547.55, up 1.18% on the day as on 12:49 IST on the NSE. The stock is up 87.16% in last one year as compared to a 25.22% g